Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects

Immune-checkpoint blockade (ICB) demonstrated inspiring effect and great promise in anti-cancer therapy. However, many obstacles, such as drug resistance and difficulty in patient selection, limited the efficacy of ICB therapy and awaited to be overcome. By timely identification and intervention of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianhang, Liu, Tianyao, Zhu, Wenjie, Xie, Shangxun, Zhao, Zihan, Feng, Baofu, Guo, Hongqian, Yang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365012/
https://www.ncbi.nlm.nih.gov/pubmed/34408525
http://dx.doi.org/10.1177/11795549211035540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365012/
https://www.ncbi.nlm.nih.gov/pubmed/34408525
http://dx.doi.org/10.1177/11795549211035540

Ejemplares similares